SCHEMBL4842592

SCHEMBL4842592

COc1ccc2c(c1)C(=CC(=O)c1ccc(NS(=O)(=O)c3ccccc3-c3ccccc3)cc1)NC(C)(C)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
LMNA P02545 3/20 0.40
NPC1 O15118 2/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
RORC P51449 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PLAU P00749 2/20 0.38
ALOX12 P18054 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
BCL2L1 Q07817 1/20 0.37
MCL1 Q07820 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842586 1.00 MAPT (0.40) MAPTLMNANPC1HTTALDH1A1
SCHEMBL4838075 0.92 MAPT (0.39) MAPTLMNANPC1HTTALDH1A1
SCHEMBL4838064 0.92 MAPT (0.39) MAPTLMNANPC1HTTALDH1A1
SCHEMBL4834732 0.89 SMN1; SMN2 (0.39) MAPTLMNANPC1HTTALDH1A1
SCHEMBL4834736 0.89 SMN1; SMN2 (0.39) MAPTLMNANPC1HTTALDH1A1
SCHEMBL4844730 0.89 PLAU (0.48) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4844743 0.89 PLAU (0.48) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4846544 0.87 SMN1; SMN2 (0.54) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4846537 0.87 SMN1; SMN2 (0.54) LMNAALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4835755 0.85 LMNA (0.41) MAPTLMNANPC1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 MAPT 646/4885LMNA 3014/4885NPC1 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.